US CDC will not publish report showing COVID vaccine benefits, Washington Post reports
22/04/2026 10:02
April 22 (Reuters) - A report showing the efficacy of the COVID-19 vaccine that was previously delayed by the head of the U.S. Centers for Disease Control and Prevention has been blocked from being published in the agency’s flagship scientific journal, the Washington Post reported on Wednesday. Reuters could not immediately verify the report which cited three people familiar with the decision. (Reporting by Rhea Rose Abraham in Bengaluru; Editing by Andrew Heavens) ((RheaRose.Abraham@thomsonreuters.com;))
Recent news on Novavax
See all newsNovavax shareholder Shah Capital to step back from activist role
Brief: Mabion Signs Deal With Novavax Expanding Cooperation To Analytical Services For Early-Stage Pipeline Projects
Brief: Sanofi Spokesperson Says Nuvaxovid to Be Available Across U.S. for 2026-27 Respiratory Virus Season
US FDA approves updated COVID vaccines for 2026-27 season
US STOCKS-Wall St rises as yields ease, Moderna lifts healthcare stocks